- Posted June 06, 2014
- Tweet This | Share on Facebook
Michigan, 43 states settle with GlaxoSmithKline
LANSING (AP) - A multinational drugmaker is paying Michigan, 43 other states and the District of Columbia $105 million to settle complaints that the company unlawfully marketed three drugs.
Michigan Attorney General Bill Schuette announced Wednesday that Michigan's share of the settlement is $2.6 million. The settlement resolves allegations that London-based GlaxoSmithKline illegally marketed Advair, Paxil and Wellbutrin for purposes that hadn't been approved by the Food and Drug Administration.
GSK is prohibited from disseminating information that describes any so-called off-label use.
The asthma drug Advair is Glaxo's best-selling product. Paxil and Wellbutrin are antidepressants.
Published: Fri, Jun 06, 2014
headlines Oakland County
- Presidents recognized
- Supreme Court justices tell Congress their safety is at risk and more must be spent on security
- As cyclospora illnesses surge to a record, Michigan officials eye lettuce as a possible cause
- ACLU leader and social justice advocate to receive ABA Thurgood Marshall Award
- Health and Housing Summer Fest hosted in Royal Oak
headlines National
- ABA connects death row inmate to pro bono attorneys who help free him
- ACLU and BigLaw firm use ‘Orange is the New Black’ in hashtag effort to promote NY jail reform
- 2 judges suspended in separate cases after being indicted on criminal charges
- Convicted ex-judge gets $5K fine but no prison time in immigration case
- Ohio governor signs bill prohibiting foreign litigation funding
- Many small firms collect payments faster than BigLaw counterparts, new data shows
